Furthermore, human diseases mimicking Lmna−/− mice—muscular dystrophy and progeroid syndromes—targeted inhibition of S6K1 might be an effective therapeutic approach, whereas not as powerful as rapamycin but might limit associated immunosuppressive side effects. The gene discussed is RPS6KB1; the disease is progeroid syndrome.